HCA Healthcare stock stumbled on heavy trading volume Tuesday after the company lowered its fiscal year 2026 earnings guidance.

At the conclusion of Tuesday's trading session, HCA shares (NYSE: HCA) were priced at $363.60, down 6.95 percent (a drop of $27.14 per share).